Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-03-04
1994-04-26
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514445, 549 59, 549 65, 549 75, 549 77, 544182, 544216, 544333, 544357, 544405, 546284, 546329, 546339, 548205, 548214, 548235, 548247, A61K 3138, A01N 4306, C07D41110, C07D33310
Patent
active
053067282
ABSTRACT:
Substituted amine derivatives represented by the general formula ##STR1## wherein Q is -C-D-E- F-G-M- or -N-H-I-J-K-L- [C, D, E, F, G, H, I, J, K and L are each O, S, a carbonyl group, -CHR.sup.2 -, -R.sup.b = or -NR.sup.c - (R.sup.a, R.sup.b and R.sup.c are each H or a lower alkyl group), M and N are each an aromatic ring of 5-6 members optionally having a halogen, OH, LN, a lower alkyl group or a lower alkoxy group, provided that L is not O, S, or -NR.sup.c -]; R is a heterocyclic ring of 5-6 members; R.sup.1 is H, a lower alkyl group, a lower haloalkyl group, a lower alkenyl group, a lower alkynyl group or a cycloalkyl group; R.sup.2, R.sup.3, R.sup.4, R.sup.5 R.sup.6 and R.sup.7 are each H, a halogen or a lower alkyl group or two of them denote a single bond; R.sup.8 and R.sup.9 are each F, CF.sub.3 or a lower alkyl group or are a cycloalkane in combination thereof; and R.sup.10 is H, F, CF.sub. 3 an acetoxy group, a lower alkyl group or a lower alkoxy group. These compounds inhibit biosynthesis of cholesterol in mammals by inhibiting their squalene epoxidase, and thereby lower their blood cholesterol values. Therefore, these compounds are expected to be effective as an agent for treatment and prophylaxis of diseases caused by excess of cholesterol, for example, obesity, hyperlipemia and arteriosclerosis and heart and encephalic diseases accompanying them.
REFERENCES:
patent: 3639476 (1972-02-01), Eberle et al.
Fessenden et al., Organic Chemistry, 2nd ed. (1982) pp. 714-715.
Chemical Abstracts 113(19):171, 868 (Takezawa) Abstract of WO90/05,132 (1990).
Chemical Abstracts 113(23):211,837 (Tsucha) Abstract of JP Koho 02,169,571 (1990).
Chemical Abstracts 114(3):17 392z (Tsuchiya) Abstract of J. Biol. Chem 1990 265(30) 18075-18078.
Chemical Abstracts 115(9):85181a (Hidaka) Abstracts of J. Biol. Chem. 1991 266(20) 13171-13177.
Chemical Abstracts 99(25)212,414 (Stuetz) Abstract of DE 3,302,814; (Feb. 1982).
Chemical Abstracts 100(11) 85,436c (Stuetz) Abstract of DE 3,316,093; (May 1982).
Chemical Abstracts 105(21)190,645 (Stuetz) Abstract of CH 656 378 (May. 1983).
Chemical Abstracts 111(25) 232,287 (Takezawa) Abstract of EP 318 860 (1989).
JP-A-03 141 275, Patent Abstracts of Japan, vol. 15, No. 357 (C-866), Sep. 10, 1991, "Substituted Allylamine Derivative and its Use", Banyu Pharmaceut Co. Ltd.
Hayashi Masahiro
Iwasawa Yoshikazu
Kamei Toshio
Masaki Hitoshi
Nagata Yasufumi
Banyu Pharmaceutical Co. Ltd.
Grumbling Matthew V.
Shah Mukund J.
LandOfFree
Substituted amine derivatives having antihyperlipemia activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted amine derivatives having antihyperlipemia activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted amine derivatives having antihyperlipemia activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1712006